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Abstract 
 
Cervical cancer is a malignant disease that causes problems in women's health, especially in developing countries such as Indonesia. 
Cervical cancer cells will develop quickly, uncontrollably, and will continue to divide and then infiltrate the surrounding t issue and 
continue to spread to connective tissue, blood, and attack important organs and spinal nerves. The aim of the research is to study the 
mathematical model of cervical cancer by chemotherapy treatment. The results of this study are that cervical cancer treatment using 
chemotherapy is effective enough to kill abnormal cells such as infected cells, pre-cancerous cells and cancer cells, although there are side 
effects, namely the killing of normal cells due to chemotherapy drugs. 
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INTRODUCTION 
 
Cervical cancer is an excessive and uncontrolled cell 
growth around the cervix (Walboomers et. al., 1999). 
Cervical cancer originated from cells in the cervix 
(Naganawa et al., 2005). Most cervical cancers begin in 
the transformation zone which is a shift from squamous 
cell type to cylindrical cell type. These cells do not 
directly turn into cervical cancer. Normal cervical cells 
due to the influence of carcinogenic substances can 
develop gradually into pre-cancerous cells and then 
become cancer cells (Sari et al., 2016).  
The main trigger for the emergence of cervical 
cancer is infection of several types of high-risk Human 
Papilloma Virus (HPV) which causes proliferation of the 
epidermal surface and cervical mucosa (Bosch, 1995). 
The types of HPV that are very common in cases of 
cervical cancer are types 16 and 18, which is more than 
70% of all cervical cancers reported. The results of a 
study of 1,000 samples from 22 countries proved the 
presence of HPV infection in 99.7% of cervical cancer 
cases (Wuryanti et. al., 2015). Cervical cancer is the 
second most common type of cancer in women 
worldwide to breast cancer (Boice et. al., 2002). 
Chemotherapy is a kind of cancer treatment that uses 
drugs to destroy cancer cells. Chemotherapy works by 
stopping or slowing the growth of cancer cells, which 
grow and divide rapidly. Chemotherapy can also harm 
healthy cells that divide rapidly, such as the lines of the 
mouth and intestines or cells that affect growth. Damage 
to healthy cells can cause side effects. Often, side effects 
will be disappear after chemotherapy is complete (Rose 
et. al., 1999). Reduction of the mass of cervical cancer 
can be used as used to measure the effectiveness of 
treatment because chemotherapy can cause shrinkage of 
the mass of cervical cancer. Cancer mass has an 
important role to detect the prognosis of a cervical 
cancer. 
 
 
FORMULATION OF MODEL 
 
This model developed frpm the past research (Asih, et. 
al., 2015) about the development of cervical cancer and 
Pillis et al. (2007) about the model of treating cancer in 
general with chemotherapy. 
 
 
 
 
 
Figure 1. Cervical Cancer Treatment Diagram by Chemotherapy. 
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Table 1. Subpopulations, Parameters and units. 
 
Symbol Symbol Explanation Unit Unit 
S(t) Normal cell density cell/mm2 
I(t) Infected cell density cell/mm2 
P(t) Pre-cancerous cell density cell/mm2 
C(t) Cancer cell density cell/mm2 
V(t) Virus density virus/mm2 
M(t)
 
Concentration of chemotherapy 
drugs 
mg/m2 
r Growth rate of normal cell 1/day 
N  Homeostatic carrying capacity  cell/mm3 
  The rate of infection 1/(day.virus) 
1a  
The rate of proliferation of 
infected cells 
1/day 
1d  
The rate of infected cell apoptosis 1/day 

 
The rate of progression, from 
infection to pre-cancer 
1/day 
2a  
The rate of proliferation of pre-
cancerous cell 
1/day 
2d  
The rate of pre-cancerous cell 
apoptosis 
1/day 

 
The maximum invasion rate, from 
precancerous to cancer 
1/day 
K
 
Half-saturation consentration  cell/mm3 
3a  
Cancer cell proliferation rate 
 
1/day 
3d  
Summing the rate of apoptosis and 
the rate of cancer cell metastasis 
1/day 
n
 
The average number of viruses 
produced by an infected cell
 
constant 
4d  
The rate of virus death 1/day 
Sk  
Fractional susceptible cells kill by 
chemotherapy 
1/day 
Ik  
Fractional infected cells kill by 
chemotherapy 
1/day 
Pk  
Fractional pre-cancerous cells kill 
by chemotherapy 
1/day 
Ck  
Fractional cancer cells kill by 
chemotherapy 
1/day 

 
The rate of chemotherapy drug 
decay 
1/day 
Mv  
The rate of chemotherapy drug 
intake 
mg/m2.day 
 
The dynamics of changes in cervical cells from 
normal cells to cancer cells are given in the following 
system of differential equations: 
 
1 S
dS S I
rS SV k MS
dt N

 
    
 
 
(1a) 
 
1 1 I
dI
SV a I d I I k MI
dt
     
 
(1b) 
 
1 1 4
dV
n d I d V
dt
 
 
(1c) 
2
2 2 2 2 P
dP P
I a P d P k MP
dt K P

    
  
(1d) 
 
2
3 32 2 C
dC P
a C d C k MC
dt K P

   

 
(1e) 
 
M
dM
M v
dt
  
  
(1f) 
 
Let  
1 1 2 2 3 3 1 1
1 1 1 1 4
, , , , ,
, , , , ,
S I
a d a b a d k d a S I
N N
P C N
P C n n d N c d p
K K K K


       
       
 
By non-conventionalizing the System (1a) - (1f) to 
be 
 
  1 1 1 1 1 11 S
dSdS
rS S I S V k MS
dt dt
     
 
(2a) 
 
1
I
dIdI
SV aI I k MI
dt dt
     
 
(2b) 
 
dV
nI cV
dt
 
 
(2c) 
 
2
1
121
p
dP P
pI bP k MP
dt P
    

 
(2d) 
 
2
21
C
dC P
kC k MC
dt P
  

 
(2e) 
 
M
dM
M v
dt
  
 
(2f) 
 
By eliminating the variable index, System (2a) - (2f) 
which is non-professional becomes 
 
  1 S
dS
rS S I SV k MS
dt
      (3a) 
 
I
dI
SV aI I k MI
dt
      (3b) 
 
dV
nI cV
dt
 
 
(3c) 
 
2
21
P
dP P
pI bP k MP
dt P

   

 (3d) 
 
2
21
C
dC P
kC k MC
dt P

  

 (3e) 
 
M
dM
M v
dt
    (3f) 
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EQUILIBRIUM POINT 
 
Theorem 1. Let 3 22 9 27 , 3u x xy z v x y     .  
The equilibrium point with chemotherapy in cervical 
cancer from System (3a) - (3f) is 
 
 
* * * * * *
3 4 5 5 2 5 1
, , , , ,
, , , , ,i i
EP S I P C V M
p c      

   
1 2 3i , , , where 1 0
Mv

  , 2 0
n
c
   , 13 1
Sk
r

   , 
2
4 1 0
r


 
    
 
,  
1 2 3
5
2 4
Ia k   
 
  
 , 5
1
,
P
p
x
k b
  




 
51
1 1
, .P
P P
pk b
y z
k b k b
 
 

  
 
 
 
Proof. 
From equation (3f) is obtained 
1 0
MvM 

   . (4) 
From equation (3c) is obtained  
2
nI
V I
c
  , (5) 
where 2 0
n
c
   . 
If equation (4) and equation (5) are substituted into 
equation (3a), then we obtain 
 
3 4S I   , (6) 
 
where 13 1
Sk
r

    and  24 1
r


 
   
 
. 
 
If equations (4), (5) and (6) are substituted in equation 
(3b), they are obtained 
 
0I   or 1 2 3 5
2 4
Ia kI
   

 
  
  ,
 
(7) 
 
where 1 2 35
2 4
Ia k   
 
  
 .
   
  
 
For 𝐼 = 0 impossible, because the virus is the cause of 
cervical cancer, so it was chosen 𝐼 = 𝜉5. If equation (4) 
and equation (7) are substituted into equation (1d), then 
they are obtained 𝑃3 + 𝑥𝑃2 + 𝑦𝑃 + 𝑧 = 0, where 
 
5 51
1 1 1
, , .P
P P P
p pk b
x y z
k b k b k b
    
  
 
   
  
 
 
 
The roots are 
2 33
1
2 33
1 1
4
3 3 2
1 1
4 ,
3 2
x
p u u v
u u v
      
  
  
  
, 
2 33
2
2 33
1 3 1
4
3 6 2
1 3 1
4
6 2
x i
p u u v
i
u u v
       
  
   
  
2 33
3
2 33
1 3 1
4
3 6 2
1 3 1
4 .
6 2
x i
p u u v
i
u u v
       
 
   
 
  (8) 
 
If equation (4) and equation (8) are substituted into 
equation (3e), then they are obtained 𝐶 =
𝜃𝑝𝑖
2
(𝑘+𝑘𝐶𝜉1)(1+𝑝𝑖2)
= 𝑐𝑖, where 𝑖 = 1,2,3.■ 
 
Theorem 2. If 1 2 3 0Ia k       , 3 4 5 0     
and if one 𝑝𝑖 > 0 and real, then the equilibrium point 
with chemotherapy or value 𝐸𝑃 exist. 
 
Proof. 
From Theorem 1 is obtained 𝑀 =
𝑣𝑀
𝛾
= 𝜉1 > 0. Because 
𝑎 + 𝛿 + 𝑘𝐼𝜉1 − 𝑎𝜉2𝜉3 > 0, then 𝐼 =
𝑎+𝛿+𝑘𝐼𝜉1−𝑎𝜉2𝜉3
𝑎𝜉2𝜉4
=
𝜉5 > 0. Because 𝐼 = 𝜉5 > 0, then 𝑉 =
𝑛𝐼
𝑐
= 𝜉2𝐼 > 0. 
Because 𝜉3 + 𝜉4𝜉5 > 0, then 𝑆 = 𝜉3 + 𝜉4𝜉5 > 0. One is 
𝑝𝑖 > 0, where 𝑖 = 1,2,3 and real. Value is 
𝜃𝑝𝑖
2
(𝑘+𝑘𝐶𝜉1)(1+𝑝𝑖2)
= 𝑐𝑖 > 0. So, the equilibrium point with 
chemotherapy or value 𝐸𝑃 exist.■ 
 
 
STABILITY 
 
Theorem 3. Let 𝑢 = 2𝑥3 − 9𝑥𝑦 + 27𝑧, 𝑣 = 𝑥2 − 3𝑦. If 
−𝑘 − 𝑘𝐶𝜉1 < 0, 𝑏 −
2𝜃𝑝𝑖
(1+𝑝𝑖2)
− 𝑘𝑃𝜉1 < 0, where 𝑖 =
1,2,3, 𝑥 > 0, 𝑢 > 0, 𝑢2 = 4𝑣3, and 𝑢 < 2𝑥3, then 
equilibrium point 𝐸𝑃 = (𝜉3 + 𝜉4𝜉5, 𝜉5, 𝜉2𝜉5, 𝑝𝑖 , 𝑐𝑖 , 𝜉1) 
asymptotic stable.
 
 
Proof.  
From System (3a) - (3f) the Jacobian matrix with 
eigenvalue is obtained 
 
 1   , 2 1Ck k    , 
 
3 12
2
2
1
i
P
i
p
b k
p

   

,
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2 33
4
2 33
1 1
4
3 3 2
1 1
4 ,
3 2
x
u u v
u u v
       
  
  
  
 
2 33
5
2 33
1 3 1
4
3 6 2
1 3 1
4
6 2
x i
u u v
i
u u v

       
  
   
  
2 33
6
2 33
1 3 1
4
3 6 2
1 3 1
4 .
6 2
x i
u u v
i
u u v

       
  
   
  
 
 
Value is 𝜆1 = −𝛾 < 0. Because −𝑘 − 𝑘𝐶𝜉1 < 0, then 
𝜆2 = −𝑘 − 𝑘𝐶𝜉1 < 0. Because 𝑏 −
2𝜃𝑝𝑖
(1+𝑝𝑖2)2
− 𝑘𝑃𝜉1 < 0, 
then 𝜆2 = 𝑏 −
2𝜃𝑝𝑖
(1+𝑝𝑖2)2
− 𝑘𝑃𝜉1 < 0. Because 𝑣 = 0, then 
𝜆4 = −
𝑥
3
−
1
3
√𝑢
3
, 𝜆5 = −
𝑥
3
−
1
3
√
1
2
𝑢
3
, 𝜆6 = −
𝑥
3
+
1
3
√
1
2
𝑢
3
. Because 𝑢 > 0, then 𝜆4 < 0. Because 𝑢 < 𝑥
3, 
then 𝜆5 = 𝜆6 < 0. Because 𝜆1, 𝜆2, 𝜆3, 𝜆4, 𝜆5 and 𝜆6, then 
the equilibrium point 𝐸𝑃 asymptotic stable.■ 
 
 
SIMULATION 
 
In this section we will discuss numerical simulations and 
medical interpretations of the mathematical model of 
cervical cancer affected by chemotherapy. First, the 
parameter values used and the initial values for each 
variable are given first. Taking parameter values for 
numerical simulations is still in the form of assumptions 
based on the rate of growth of cancer cells in general. 
Sources and interpretations of parameter values can be 
seen in the reference. The parameter values for this case 
are given in Table 2. 
 
Table 2. Case Parameter Value of the Effects of Chemotherapy. 
 
Symbol Value Reference 
𝑟 0.02 Asih et al. (2015) 
𝛼 0.0001 Asih et al. (2015) 
𝑎 0.01  Asih et al. (2015) 
𝛿
 
0.0082  Asih et al. (2015) 
𝑛
 
10000 Asih et al. (2015) 
𝑐
 
50 Asih et al. (2015) 
𝑝
 
13.44 Asih et al. (2015) 
𝑏
 
1 Asih et al. (2015) 
𝜃
 
2.03 
 
Asih et al. (2015) 
𝑘
 
1.01  Asih et al. (2015) 
𝑘𝑆
 
0.0006 Estimation 
𝑘𝐼
 
0.6 Pillis et al. (2007) 
𝑘𝑃
 
0.6 Pillis et al. (2007) 
𝑘𝐶
 
0.8 Pillis et al. (2007) 
𝛾
 
0.9 Pillis et al. (2007) 
𝑣𝑀
 
1 Pillis et al. (2007) 
 
 
 
  
 
Figure 2. System Simulation (3a) - (3f) with parameter values 𝑟 = 0, 𝛼 =
0.0001, 𝑎 = 0.01, 𝛿 = 0.0082, 𝑛 = 10000, 𝑐 = 50, 𝑝 = 13.44, 𝑏 = 1, 
𝜃 = 2.03,  𝑘 = 1.01, 𝑘𝑆 = 0.0006,  𝑘𝐼 = 0.6,  𝑘𝑃 = 0.6,  𝑘𝐶 = 0.8, 𝛾 =
0.9,  𝛾 = 1, and initial conditions (13, 13, 13, 13, 13, 13). The dynamics 
due to normal cell chemotherapy drugs, infected cells, precancerous cells, 
cancer cells, cancer cells, and viruses declined in three days. (A) normal 
cells. (B) Infected cells, precancerous cells, and cancer cells. (C) Viruses. 
(D) Chemotherapy drug concentration. 
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Figure 2 shows a trajectory with the influence of 
chemotherapy drugs, on cervical cancer patients. 
Normal cells in the first 3 days showed a decrease, from 
13 cells/mm2 to 7,254 cells/mm2. This makes a severe 
effect for cervical cancer patients with this 
chemotherapy drug. Infected cells, precancerous cells 
and cancer cells drop very quickly, in the first 3 days of 
chemotherapy, from 13 cells/mm2 to 0.01308 cells/mm2. 
The initial virus rose would derease after chemotherapy. 
The virus in 3 days is from 13 viruses/mm2 to 0.3771 
viruses/mm2. This is because, many infected cells die 
because of the effects of chemotherapy drugs. The 
chemotherapy drug on the third day still contained 
1.91mg/m2. It means that chemotherapy drugs still have 
an effect on normal cells and other abnormal cells, 
including cancer cells. 
 
 
CONCLUSION 
 
Cervical cancer is one type of malignant cancer and is 
most prevalent in women compared to other cancers. 
Treatment of cervical cancer with chemotherapy is quite 
effective. Abnormal cancer cells such as infected cells, 
precancerous cells, and many cancer cells die from this 
treatment. Because normal cells are dead, this is the side 
effect of the of this treatment. This research needs to be 
continued with other treatments that are more effective, 
especially to reduce the adverse effects to the normal 
cell. 
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